Variations in analgesic, sedation, and delirium management between trauma and non-trauma critically ill children

Steven C Mehl1,2, Megan E Cunningham2, Michael D Chance2

  • 1Michael E. DeBakey Department of Surgery, Baylor College of Medicine, Houston, TX, USA.

Insights

Critically ill children in intensive care units (ICUs) have different medication needs based on whether they are medical, surgical, or trauma patients. Understanding these differences is key for tailored treatment protocols.

Area of Science:

  • Pediatric critical care medicine
  • Pharmacology
  • Health services research

Background:

  • Intensive care unit (ICU) protocols are often based on medical patients, potentially overlooking differences in surgical and trauma populations.
  • Critically ill pediatric patients present unique challenges and may have distinct medication profiles.

Purpose of the Study:

  • To investigate and compare the medication profiles of critically ill pediatric medical, surgical, and trauma patients.
  • To identify differences in the administration of analgesics, sedatives, and other key medications among these distinct patient groups.

Main Methods:

  • Retrospective cohort study using the Pediatric Health Information System 2017 dataset.
  • Categorized patients into medical, surgical, and trauma cohorts based on ICD-10 codes.
  • Analyzed demographics, diagnoses, outcomes, and medication data (opiates, GABA-agonists, etc.) for the first 30 ICU days using Kolmogorov-Smirnov tests and odds ratios.

Main Results:

  • The trauma cohort showed higher incidences of delirium and mortality compared to medical and surgical cohorts.
  • GABA-agonists were administered to over 50% of patients across all cohorts within the first 30 ICU days.
  • Significant differences in the administration of opiates, GABA-agonists, alpha-2 agonists, anti-psychotics, and other sedatives were observed between cohorts. Trauma patients had higher odds of receiving anti-psychotics.

Conclusions:

  • Critically ill pediatric patients in medical, surgical, and trauma categories represent distinct populations.
  • Pharmacologic profiles for analgesia, sedation, and delirium management differ significantly among these pediatric ICU patient groups.
  • This highlights the need for specialized, evidence-based treatment protocols tailored to the specific needs of pediatric trauma, surgical, and medical patients.
Abstract

Related Concept Videos

Parenteral Anesthetics: Overview01:24

Parenteral Anesthetics: Overview

Intravenous anesthetics are drugs administered parenterally to induce anesthesia or sedation. Propofol is a widely used agent formulated as a 1% emulsion in soybean oil, glycerol, and egg phosphatide. It induces rapid anesthesia primarily due to its rapid distribution from the bloodstream to target tissues and is metabolized in the liver. However, it can cause significant pain on injection and hypertriglyceridemia. Fospropofol, a water-based prodrug of propofol, lacks these adverse effects.
324
Stages of General Anesthesia01:22

Stages of General Anesthesia

Various sedation levels offer significant advantages in facilitating procedural interventions for patients undergoing medical or invasive surgical procedures. These levels span from anxiolysis to general anesthesia, providing a spectrum of sedative effects to cater to specific patient needs. Anxiolysis reduces anxiety and is achieved through minimal sedation, enabling patients to remain awake and responsive while feeling more at ease during the procedure. This level can benefit minor...
914
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
18
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
33
Analgesia and Pain Management01:25

Analgesia and Pain Management

Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
917
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
20